Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.

Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes...

Full description

Bibliographic Details
Main Authors: Ashfaq Ghumra, Pongsak Khunrae, Ricardo Ataide, Ahmed Raza, Stephen J Rogerson, Matthew K Higgins, J Alexandra Rowe
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3031562?pdf=render
id doaj-37b08c9735ed468d8c450183348e8c83
record_format Article
spelling doaj-37b08c9735ed468d8c450183348e8c832020-11-25T00:07:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0161e1641410.1371/journal.pone.0016414Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.Ashfaq GhumraPongsak KhunraeRicardo AtaideAhmed RazaStephen J RogersonMatthew K HigginsJ Alexandra RoweRosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria.We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 µg/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 µg/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 µg/ml). Antibodies to the N-terminal region (NTS-DBL1α) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains.These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.http://europepmc.org/articles/PMC3031562?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ashfaq Ghumra
Pongsak Khunrae
Ricardo Ataide
Ahmed Raza
Stephen J Rogerson
Matthew K Higgins
J Alexandra Rowe
spellingShingle Ashfaq Ghumra
Pongsak Khunrae
Ricardo Ataide
Ahmed Raza
Stephen J Rogerson
Matthew K Higgins
J Alexandra Rowe
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
PLoS ONE
author_facet Ashfaq Ghumra
Pongsak Khunrae
Ricardo Ataide
Ahmed Raza
Stephen J Rogerson
Matthew K Higgins
J Alexandra Rowe
author_sort Ashfaq Ghumra
title Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
title_short Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
title_full Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
title_fullStr Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
title_full_unstemmed Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.
title_sort immunisation with recombinant pfemp1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to plasmodium falciparum.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria.We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 µg/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 µg/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 µg/ml). Antibodies to the N-terminal region (NTS-DBL1α) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains.These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.
url http://europepmc.org/articles/PMC3031562?pdf=render
work_keys_str_mv AT ashfaqghumra immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT pongsakkhunrae immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT ricardoataide immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT ahmedraza immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT stephenjrogerson immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT matthewkhiggins immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
AT jalexandrarowe immunisationwithrecombinantpfemp1domainselicitsfunctionalrosetteinhibitingandphagocytosisinducingantibodiestoplasmodiumfalciparum
_version_ 1725418091464097792